Jan. 28, 2024
by Andrii Buvailo, PhD
News
A new mission aboard SpaceX CRS-29, launching from NASA's Kennedy Space Center in Cape Canaveral, Florida, on January 30, 2024, …
Dec. 3, 2021
by Andrii Buvailo
Biopharma insight
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …
Oct. 2, 2019
by Andrii Buvailo
Biopharma insight
The race for adopting new machine learning (ML), deep learning (DL) and related technologies (for simplicity -- “artificial intelligence”/”AI”) keeps …
Jan. 11, 2024
by Andrii Buvailo
Interview
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
July 17, 2018
by Dr. Gerald J. Yakatan
Biopharma insight
China has been becoming a research powerhouse in many fields of science, but it still is a minor player when …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
Aug. 18, 2017
by BiopharmaTrend
Biopharma insight
Virtual reality (VR) has been a hot topic in game industry lately, but now it finds its way to biopharmaceutical …
Sept. 27, 2018
by Andrii Buvailo
Biopharma insight
What is a super-platform? A “super-platform” is a term which describes a relatively new phenomenon in a modern technological world …
Jan. 15, 2019
by Naheed Kurji
Biopharma insight
In this Special Perspective, our fourth in an ongoing series, we will be presenting MatchMaker™, a novel deep proteome screening …
April 2, 2017
by Andrii Buvailo
Biopharma insight
Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, …
Nov. 6, 2017
by Alfred Ajami
Biopharma insight
Pharma productivity has remained a daunting challenge, notably because R&D departments have been shuffled and reorganized over the last few …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …